GET THE APP

A Short Note on Tropical Disease
..

Journal of Infectious Diseases and Medicine

ISSN: 2576-1420

Open Access

Short Communication - (2022) Volume 7, Issue 3

A Short Note on Tropical Disease

Yafet Kesete*
*Correspondence: Yafet Kesete, Department of Allied Health Sciences, Orotta College of Medicine and Health Sciences, Asmara, Eritrea, Email:
Department of Allied Health Sciences, Orotta College of Medicine and Health Sciences, Asmara, Eritrea

Received: 08-Mar-2022, Manuscript No. jidm-22-63271; Editor assigned: 10-Mar-2022, Pre QC No. P-63271; Reviewed: 14-Mar-2022, QC No. Q-63271; Revised: 21-Mar-2022, Manuscript No. R-63271; Published: 25-Mar-2022 , DOI: 10.37421/2576-1420.2022.7.225
Citation: Kesete, Yafet. “A Short Note on Tropical Disease.” J Infect Dis Med 7 (2022): 225.
Copyright: © 2022 Kesete Y. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Description

Any disease that is native to or occurs primarily in tropical or subtropical areas of the world is known as a tropical disease. Malaria, cholera, Chagas disease, yellow fever, and dengue fever are examples of tropical diseases. Tropical and subtropical diseases have been known since antiquity. Ancient physicians, such as Hippocrates of Greece and Aulus Cornelius Celsus of Rome, wrote about malarial disorders, and current molecular analysis of Egyptian mummies have revealed that malaria existed in ancient Egypt. Later on, other tropical diseases were discovered. For example, Europeans discovered yellow fever, a disease found in tropical Africa and South America, during the Spanish invasion in the 16th century.

In the 19th century, as a result of exploration and colonial expansion, an increasing number of Europeans and Americans were exposed to infectious diseases in tropical and subtropical climates, scientific interest in the identification and classification of tropical diseases arose. Tropical medicine was founded on the study of tropical diseases. Filariasis, malaria, and yellow fever were among the first diseases studied. Many tropical diseases were discovered to be transmitted by vectors such as mosquitoes, fleas, lice, snails, and other animals in the late 19th and early 20th centuries, and certain infections were related to contaminated food or water. Many tropical diseases' pathogens (disease-causing organisms) were eventually found, including bacteria, viruses, and parasites [1-3].

The importance of tropical diseases expanded in the late twentieth and early twenty-first centuries. While certain diseases were largely managed as a result of increased awareness and breakthroughs in prevention and treatment, others became more prevalent as a result of population growth, large-scale human migration and displacement, deterioration of public health infrastructure, and tourism. In addition, formerly under control tropical diseases such as cholera, dengue fever, and meningococcal meningitis resurfaced. New diseases emerged, such as Ebola. As a result of increased human mobility and climate-driven vector movement, several tropical diseases began to spread into temperate climates. Poverty, a lack of clean water, and a lack of medical treatment all influenced the impact of a wide variety of tropical diseases.

Hundreds of millions of people are affected each year by a variety of tropical diseases, which have been identified. While many tropical illnesses have been eradicated in more industrialised countries, they continue to be major causes of sickness and mortality in impoverished, marginalised, and rural areas. These diseases, often known as neglected tropical diseases, afflict almost a billion people worldwide. African sleeping sickness, Chagas disease, dengue fever, guinea worm disease, leishmaniasis, leprosy, lymphatic filariasis, onchocerciasis, rabies, schistosomiasis, trachoma, and yaws are examples of neglected tropical diseases.

The diseases' limited international visibility, the severe economic and social challenges that afflicted regions confront, a lack of medical access in such regions, and a lack of local education about the diseases have all hampered efforts to prevent and control neglected tropical diseases. However, increased international attention in the early twenty-first century resulted in increased research funding and access to medical care in some impacted countries. Although drugs were available for only a few neglected tropical diseases, other interventions such as vector control and sanitation and hygiene improvements, as well as so-called mass drug administration, in which drugs were made available to large numbers of people, proved highly effective against the diseases [4-6]

Conclusion

Borna disease is a viral infection that causes inflammation of the brain and spinal cord in warm-blooded animals, particularly horses and sheep. It is spread through food and water contaminated by diseased animal secretions and is named after a significant outbreak in Borna, Germany, in 1894. The mortality rate could exceed 90%. Some research have suggested a link between the Borna disease virus and mental illness in humans, however this has yet to be confirmed definitively.

Conflict of Interests

None.

References

  1. Ardolino, Michele, and David H. Raulet. "Cytokine therapy restores antitumor responses of NK cells rendered anergic in MHC I-deficient tumors." Oncoimmunology 5 (2016): e1002725.
  2. Indexed at, Crossref, Google Scholar

  3. Armstrong-James, Darius, Gordon D. Brown, Mihai G. Netea and Teresa Zelante et al. "Immunotherapeutic approaches to treatment of fungal diseases." Lancet Infect Dis 17(2017): e393-e402.
  4. Crossref, Google Scholar

  5. Ashorn, Per, George Englund, Malcolm A. Martin, and Edward A. Berger et al. "Anti-HIV activity of CD4-Pseudomonas exotoxin on infected primary human lymphocytes and monocyte/macrophages." J Infect Dis 163(1991): 703-709.
  6. Indexed at, Crossref, Google Scholar

  7. Babior, Bernard M., Cindy Takeuchi, Julie Ruedi and Paul Wentworth et al. "Investigating antibody-catalyzed ozone generation by human neutrophils." Proc Natl Acad Sci USA 100(2003): 3031-3034.
  8. Indexed at, Crossref, Google Scholar

  9. Baer, Mark, Teiji Sawa, Peter Flynn and  Kenneth Luehrsen et al. "An engineered human antibody fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity." Infect Immun  77(2009): 1083-1090.
  10. Indexed at, Crossref, Google Scholar

  11. Bagley, Stephen J., Arati S. Desai, Gerald P. Linette and Donald M. O’Rourke et al. "CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges." Neuro Oncol 20(2018): 1429-1438.
  12. Indexed at, Crossref, Google Scholar

Google Scholar citation report
Citations: 59

Journal of Infectious Diseases and Medicine received 59 citations as per Google Scholar report

Journal of Infectious Diseases and Medicine peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward